Pauksens, Karlis <br/><br/>
Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults.  [electronic resource] 

 -  Clinical and vaccine immunology : CVI  May 2014 
 - 651-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-679X 
<br/><br/><label>Standard No.: </label>10.1128/CVI.00807-13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Aged<br/>Aged, 80 and over<br/>Alum Compounds--administration & dosage<br/>Antibodies, Bacterial--blood<br/>Antigens, Bacterial--immunology<br/>Bacterial Proteins--immunology<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Humans<br/>Male<br/>Opsonin Proteins--blood<br/>Phagocytosis<br/>Placebos--administration & dosage<br/>Pneumococcal Vaccines--administration & dosage<br/>Saponins--administration & dosage<br/>Single-Blind Method<br/>Streptolysins--immunology<br/>Vaccines, Subunit--administration & dosage